Brucella melitensis isolates susceptible to levofloxacin

Although brucellosis is rare in Europe and N America, the increase in bioterrorism means that brucella bacteria now present a potential threat. Researchers in the Faculty of Medicine, University of Crete, Greece, have examined the susceptibilities of Brucella melitensis isolates to eleven antibiotics.

A total of 74 strains were tested against levofloxacin, ciprofloxacin, norfloxacin, tetracycline, rifampicin, streptomycin, gentamicin, trimethoprim/sulfamethoxazole, ampicillin, amoxicillin/clavulanic acid and erythromycin. All isolates were found to be susceptible to levofloxacin, ciprofloxacin, norfloxacin, tetracycline, streptomycin and gentamicin.

PMID: 17014707

Ann. Clin. Microbiol. Antimicrob. 2006 Oct 2;5:24

Source : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=
pubmed&dopt=Abstract&list_uids=17014707